Neurogene (NGNE)
24.90
-1.18 (4.52%)
Upcoming Events
Latest Headlines
Neurogene Announces Upcoming Presentations Highlighting Key Differentiators of NGN-401 for Rett Syndrome at the ESGCT 33rd Annual Congress
October 20, 2026 7:30 AM - BizWire
JPMorgan Starts Neurogene (NGNE) at Overweight
October 8, 2026 3:14 AM - StreetInsider
Form SCHEDULE 13G Neurogene Inc. Filed by: PRUDENTIAL FINANCIAL INC
October 7, 2026 11:08 AM - SEC Filing
Jennison Associates LLC reports 11.1% passive stake in Neurogene as of Sept 30 - SEC filing
October 6, 2026 1:56 PM - StreetInsider
Form SCHEDULE 13G Neurogene Inc. Filed by: JENNISON ASSOCIATES LLC
October 6, 2026 1:50 PM - SEC Filing
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 5, 2026 4:01 PM - BizWire
Form 4 Neurogene Inc. For: Sep 22 Filed by: McMinn Rachel
October 2, 2026 2:49 PM - SEC Filing
Form SCHEDULE 13G/A Neurogene Inc. Filed by: Redmile Group, LLC
August 14, 2026 4:25 PM - SEC Filing
Form SCHEDULE 13G/A Neurogene Inc. Filed by: Trails Edge Capital Partners, LP
August 14, 2026 4:23 PM - SEC Filing
Form SCHEDULE 13G Neurogene Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
August 14, 2026 6:14 AM - SEC Filing
Neurogene (NGNE) PT Lowered to $65 at H.C. Wainwright
August 12, 2026 7:21 AM - StreetInsider
Neurogene (NGNE) PT Lowered to $166 at Canaccord
August 12, 2026 6:51 AM - StreetInsider
Form 10-Q Neurogene Inc. For: Jun 30
August 11, 2026 4:58 PM - SEC Filing
Neurogene (NGNE) Tops Q2 EPS by 38c
August 11, 2026 7:35 AM - StreetInsider
Form 8-K Neurogene Inc. For: Aug 11
August 11, 2026 7:33 AM - SEC Filing
Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates
August 11, 2026 7:30 AM - BizWire
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 4, 2026 4:01 PM - BizWire
Newleos Names Rohan Palekar as Board Chairman
July 28, 2026 7:00 AM - BizWire
Full Article List
